Traumatic Encephalopathy

Traumatic Encephalopathy is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.

July 17, 2020
Open Access

Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease Therapy

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Lazhar ZribiFakher Chabchoub
July 28, 2020

The Neuropathology of Chronic Traumatic Encephalopathy: The Status of the Literature

Seminars in Neurology
Ann C McKee
August 6, 2020
Open Access

Differential protein expression in diverse brain areas of Parkinson's and Alzheimer's disease patients

Scientific Reports
A R Esteves, S M Cardoso
July 23, 2020
Open Access

Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI

Scientific Reports
Mackenzie L CarlsonMichael M Zeineh
August 5, 2020
Open Access

Defining and predicting transdiagnostic categories of neurodegenerative disease

Nature Biomedical Engineering
Eli J CornblathDanielle S Bassett
July 28, 2020
Review

Role of environmental pollutants in Alzheimer's disease: a review

Environmental Science and Pollution Research International
Reyaz Hassan MirMubashir Hussain Masoodi
July 21, 2020

Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer's disease or should they be looking elsewhere?

Expert Opinion on Drug Discovery
Bruno Pietro ImbimboMark Watling
July 30, 2020

Development and Evaluation of [125 I]IPPI for Tau Imaging in Post-Mortem Human Alzheimer's Disease Brain

Synapse
Jogeshwar MukherjeeRommani Mondal
August 1, 2020
Preprint
Open Access

Multiplexed fractionated proteomics reveals synaptic factors associated with cognitive resilience in Alzheimer's Disease

BioRxiv : the Preprint Server for Biology
Becky Catherine CarlyleS. E. Arnold
July 18, 2020

Viral Delivery of Non-Mutated Human Truncated Tau to Neurons Recapitulates Key Features of Human Tauopathy in Wild-Type Mice

Journal of Alzheimer's Disease : JAD
Thomas VogelsTomáš Hromádka
July 24, 2020
Review

Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease

Annals of the New York Academy of Sciences
Mazel MihardjaLee Wei Lim
August 5, 2020

Influences of impact scenarios and vehicle front-end design on head injury risk of motorcyclist

Accident; Analysis and Prevention
Zhi XiaoChunhui Yang
July 17, 2020
Open Access

18F-MK-6240 PET for early and late detection of neurofibrillary tangles

Brain : a Journal of Neurology
Tharick A PascoalPedro Rosa-Neto
August 3, 2020
Review

Neuropathological assessment of the Alzheimer spectrum

Journal of Neural Transmission
Kurt A Jellinger
July 25, 2020
Preprint
Open Access

THE RELATIONSHIP OF THE FOOT AND ANKLE STRUCTURE WITH OVERUSE INJURIES IN LICENSED FOOTBALLERS, A PROSPECTIVE COHORT

MedRxiv : the Preprint Server for Health Sciences
Ali sahillioglu, l. cerrahoglu

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/traumatic-encephalopathy/1b2b80cf-72aa-4b1d-b970-381b7ef58e3e